ALG11 Antikörper

Produktnummer ABIN634995

Dieses Anti-ALG11-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von ALG11 in WB. Geeignet für Human, Maus und Ratte.

Kurzübersicht für ALG11 Antikörper (ABIN634995)

Target: ALG11 (Asparagine-Linked Glycosylation 11, alpha-1,2-Mannosyltransferase Homolog (Yeast) (ALG11))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ALG11 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-ALG11 Antikörper

Spezifität: ALG11 antibody was yeast alpha-12-mannosyltransferase

Aufreinigung: Affinity purified

Immunogen: ALG11 antibody was raised using a synthetic peptide corresponding to a region with amino acids LSEDLGVQEYVEFKINIPFDELKNYLSEATIGLHTMWNEHFGIGVVECMA

Anwendungsinformationen

Applikationshinweise: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

ALG11 Blocking Peptide, (ABIN5612018), is also available for use as a blocking control in assays to test for specificity of this ALG11 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ALG11 antibody in PBS

Konzentration: Lot specific

Buffer: PBS

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Details zu ALG11

Target: ALG11 (Asparagine-Linked Glycosylation 11, alpha-1,2-Mannosyltransferase Homolog (Yeast) (ALG11))

Andere Bezeichnung: ALG11

Hintergrund: ALG11 is a GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase which is localized to the cytosolic side of the endoplasmic reticulum (ER) and catalyzes the transfer of the fourth and fifth mannose residue from GDP-mannose (GDP-Man) to Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol resulting in the production of Man5GlcNAc2-PP-dolichol. Mutations in this gene are associated with congenital disorder of glycosylation type Ip (CDGIP).

Molekulargewicht: 56 kDa (MW of target protein)

Pathways: SARS-CoV-2 Protein Interaktom